Endometrial cancer cell lines treated with eribulin and paclitaxel
Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics, leading to inhibition of microtubule growth in the absence of effects on microtubule shortening at microtubule plus ends, and formation of nonproductive tubulin aggregates. In this study, we investigated whether selective signal pathways were associated with eribulin activity compared to paclitaxel, which stabilizes microtubules, based on gene expression profiling of cell line panels of breast, endometrial, and ovarian cancer in vitro.
Cancer Type: Ovarian Cancer
GPL: 570
Number of Genes with Data: 978
Number Observations: 168
Number Outputs: 1
Imbalanced Ratio: 0.486725664
Default Task: Classification